This is the authors' abstract. We don't add key points for this paper.
studies revealed that N3@437 under 808 nm laser irradiation achieved 94.9% tumor growth inhibition and markedly suppressed lung metastasis. By employing a triple-pronged strategy of molecular engineering, nanocarrier design, and pathway blockage, this work pioneered a paradigm that concurrently depletes GSH and inhibits HSPs. This breakthrough enables enhanced PDT/PTT performance, offering a transformative solution for combating tumor adaptive resistance.
No takes yet. Share an insight, caveat, or question.
Tu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: